Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Latest Presentations
View All

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
July 23, 2024
Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity
See Details
July 23, 2024
Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
See Details
Upcoming Events
August 6, 2024 at 8:00 AM EDT
Rhythm Pharmaceuticals 2Q 2024 Earnings Conference Call
See Details
August 13, 2024 at 11:00 AM EDT
Canaccord Genuity 44th Annual Growth Conference
See Details
Investor FAQs
More FAQs are coming soon.

Founded

Delaware, November 2008

Headquarters

222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number

76243J105

Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120